Novo CEO pressed by Senate to chop prices of being overweight, diabetic issues medication CEO Lars Fruergaard Jørgensen informed lawmakers the company would consider new talks with insurers with regard to the checklist rates of Wegovy and copyright if they pledge to maintain the medicines on their formularies. The deal https://zanewyyzz.blogpixi.com/30921777/everything-about-healthcare-news